Roche receives FDA approval for expanded use of the CINtec PLUS Cytology test to aid clinicians in preventing cervical cancer

  • Next-generation biomarker cytology test supports World Health Organization’s goal to eliminate cervical cancer, which is nearly 100 percent preventable with proper screening, vaccination and treatment –
  • New indication allows this first FDA-approved biomarker-based test to be used as triage for positive cobas HPV tests run on cobas 6800/8800 Systems in primary screening or co-testing programs
  • More sensitive than traditional Pap cytology, this test allows clinicians to determine which HPV-positive women require further diagnostic procedures to prevent disease progression

Continue reading

White Hat Life Science Investor Conference Creates Opportunities for Innovators and Investors

The White Hat Life Science Investor Conference, a biotech and healthcare investor conference, will showcase exciting biotech and medtech companies from across the Rocky Mountain & Southwest Region in an all digital format September 13 – 19, 2020 during Arizona Bioscience Week.

Investors and other attendees will have the opportunity to connect with a new generation of biotech and healthcare pioneers using virtual meetings via the Arizona Bioscience Week app.Continue reading

Lab Tests: ClōSYS Oral Rinse Eliminated COVID-19 Virus up to 98.4% in 30 Seconds

SCOTTSDALE, Ariz. (Aug. 31, 2020) — Rowpar Pharmaceuticals Inc., the makers of the ClōSYS brand of toothpastes, mouthwashes and oral sprays, announced today that an in vitro laboratory analysis showed that ClōSYS Ultra Sensitive Oral Rinse reduced SARS-CoV-2 (COVID-19 virus) up to 98.4% within 30 seconds without the use of any harsh chemicals like alcohol, hydrogen peroxide or povidone iodine.Continue reading